Norditropin FlexPro / Norditropin NordiFlex

ICH M15 guideline on general principles for model-informed drug development - Scientific guideline

ICH M15 Guideline on general principles for model-informed drug development - Step 5

Human medicines European public assessment report (EPAR): Adenuric, febuxostat, Date of authorisation: 21/04/2008, Revision: 24, Status: Authorised

Healthcare Professionals' Working Party (HCPWP) plenary meeting February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, 3 February 2026

Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Elucirem, gadopiclenol, Date of authorisation: 07/12/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Vueway, gadopiclenol, Date of authorisation: 07/12/2023, Revision: 4, Status: Authorised

Aliskiren product-specific bioequivalence guidance

PhV non-compliance notification contact points at National Competent Authority (NCA) level